Dfn-15
Orthopaedic Fractures
Major Extremity Trauma Research ConsortiumPhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Orthopaedic Fractures cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Naproxen Major Extremity Trauma Research Consortium | Phase 3 | BB |
DICLOFENAC Major Extremity Trauma Research Consortium | Phase 3 | BB |
Same molecule, other indications
Dfn-15 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →